Guidance Capital »

Supernus Pharmaceuticals shares owned by Guidance Capital

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Guidance Capital from 13F filings

Historical chart of Guidance Capital investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Guidance Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Guidance Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $661k 13k 49.19

More positions owned by Guidance Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr Ultra Short Dur (ICSH)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Growth Etf (VUG)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Trust Ishare 0-1 (SHV)
Microsoft Corporation (MSFT)

View all positions for Guidance Capital

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management

View all funds holding Supernus Pharmaceuticals